Clinuvel Pharmaceuticals

(OTC) CLVLY

Current Price$6.70

Market Cap$337.75M

Since IPO (2004)+4%

5 Year-69%

1 Year-11%

1 Month-7%

Clinuvel Pharmaceuticals Financials at a Glance

Market Cap

$337.75M

Revenue (TTM)

$186.65M

Net Income (TTM)

$71.12M

EPS (TTM)

$0.41

P/E Ratio

16.09

Dividend

$0.03

Beta (Volatility)

0.69 (Low)

Dividend

$0.03

Beta (Volatility)

0.69 (Low)

Price

$6.70

Volume

Open

$7.09

Price

$6.70

Volume

Open

$7.09

Previous Close

$6.70

Daily Range

$6.70 - $7.09

52-Week Range

$6.00 - $9.00

Dividend

$0.03

Beta (Volatility)

0.69 (Low)

Price

$6.70

Volume

Open

$7.09

Previous Close

$6.70

Daily Range

$6.70 - $7.09

52-Week Range

$6.00 - $9.00

CLVLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clinuvel Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Lachlan Hay

Website

www.clinuvel.com

Headquarters

Melbourne, VIC 3000, AU

CLVLY Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

39%

Net Income Margin

34%

Return on Equity

14%

Return on Capital

15%

Return on Assets

12%

Earnings Yield

6.22%

Dividend Yield

0.49%

Payout Ratio

7.70%

Stock Overview

Market Cap

$337.75M

Shares Outstanding

50.41M

Volume

Avg. Volume

2.11K

Financials (TTM)

Gross Profit

$79.14M

Operating Income

$45.73M

EBITDA

$57.20M

Operating Cash Flow

$41.10M

Capital Expenditure

$298.57K

Free Cash Flow

$40.80M

Cash & ST Invst.

$224.11M

Total Debt

$528.53K

Clinuvel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$36.25M

+12.4%

Gross Profit

$20.37M

+20.4%

Gross Margin

56.19%

N/A

Market Cap

$337.75M

N/A

Market Cap/Employee

$3.38M

N/A

Employees

100

N/A

Net Income

$10.25M

-6.3%

EBITDA

$11.25M

-22.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$232.43M

+34.1%

Accounts Receivable

$16.57M

+26.7%

Inventory

$8.40M

-33.1%

Long Term Debt

$34.46K

-95.2%

Short Term Debt

$306.29K

-13.9%

Return on Assets

12.07%

N/A

Return on Invested Capital

15.06%

N/A

Free Cash Flow

$12.15M

-42.4%

Operating Cash Flow

$12.30M

-53.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NWBONorthwest Biotherapeutics, Inc.

NWBONorthwest Biotherapeutics, Inc.$0.20+0.00%

CYDYCytoDyn Inc.

CYDYCytoDyn Inc.$0.31+0.09%

CMVLFCellectis S.A.

CMVLFCellectis S.A.$3.08-30.00%

BOVNFBioInvent International AB (publ)

BOVNFBioInvent International AB (publ)$3.29+0.00%

PTCHFPureTech Health plc

PTCHFPureTech Health plc$1.92+13.81%

IOBCFIon Beam Applications S.A.

IOBCFIon Beam Applications S.A.$16.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.98+0.02%

Questions About CLVLY

What is the current price of Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals is trading at $6.70 per share.

What is the 52-week range for Clinuvel Pharmaceuticals?

Over the past 52 weeks, Clinuvel Pharmaceuticals has traded between $6.00 and $9.00.

How much debt does Clinuvel Pharmaceuticals have?

As of the most recent reporting period, Clinuvel Pharmaceuticals reported total debt of $346,370.825.

How much cash does Clinuvel Pharmaceuticals have on hand?

Clinuvel Pharmaceuticals reported $18.36M in cash and cash equivalents in its most recent financial results.

What is Clinuvel Pharmaceuticals’s dividend yield?

Clinuvel Pharmaceuticals currently has a dividend yield of 0.49%.

Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Financials at a Glance

CLVLY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Clinuvel Pharmaceuticals

CLVLY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Clinuvel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLVLY

What is the current price of Clinuvel Pharmaceuticals?

What is the 52-week range for Clinuvel Pharmaceuticals?

How much debt does Clinuvel Pharmaceuticals have?

How much cash does Clinuvel Pharmaceuticals have on hand?

What is Clinuvel Pharmaceuticals’s dividend yield?

Premium Investing Services